IRADIMED CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 43.85 USD | +4.40% |
|
+5.74% | -7.63% |
| 02/05 | Transcript : IRADIMED CORPORATION, Q1 2024 Earnings Call, May 02, 2024 | |
| 02/05 | Earnings Flash (IRMD) IRADIMED CORPORATION Posts Q1 Revenue $17.6M | MT |
Chart calendar IRADIMED CORPORATION
8bf54a533d5c63072279392985b3eb.3dUt9877FtRvYtSe1tuF4M-aoyUJveNWwvfzdrQnw9M.7YwchoqBfosZOqLRmI7y0Yzg-21C_rEdpYW4IoJShuSJoW6tppRn5UIXpw~52743e7f0a8e41d9f402cc29193c7297
Upcoming events on IRADIMED CORPORATION
Past events on IRADIMED CORPORATION
| 02/05/2024 08:30 pm | Q1 2024 Earnings Call |
| 02/05/2024 06:00 pm | Q1 2024 Earnings Release |
| 20/03/2024 01:00 am | Roth Conference |
| 03/03/2024 | Anesthesiologists World Congress |
| 28/02/2024 | European Society of Radiology Conference |
| 08/02/2024 09:30 pm | Q4 2023 Earnings Call |
| 08/02/2024 06:35 pm | Q4 2023 Earnings Release |
| 01/02/2024 08:45 pm | Lytham Partners Investor Select Conference |
| 12/01/2024 01:30 am | JPMorgan Healthcare Conference |
| 03/11/2023 08:30 pm | Q3 2023 Earnings Call |
| 03/11/2023 05:30 pm | Q3 2023 Earnings Release |
| 14/09/2023 | Lake Street Capital Markets Big7 Conference |
| 13/09/2023 | Singular Research Autumn Equinox Conferece |
| 12/09/2023 | H.C. Wainwright Global Investment Conference |
| 03/08/2023 08:30 pm | Q2 2023 Earnings Call |
| 03/08/2023 05:30 pm | Q2 2023 Earnings Release |
| 22/06/2023 06:30 pm | Singular Research Summer Solstice Conference |
| 15/06/2023 | Annual General Meeting |
| 04/05/2023 08:30 pm | Q1 2023 Earnings Call |
| 04/05/2023 06:00 pm | Q1 2023 Earnings Release |
Past dividends on IRADIMED CORPORATION
| 21/12/2023 | Quarterly 0.63 USD |
| 10/02/2023 | 1.05 USD |
| 16/02/2022 | 1 USD |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 38,5 38,6 -0.18% | 31,7 31,2 1.69% | 41,8 41,6 0.5% | 53,3 53,4 -0.12% | 65,6 65,6 -0.06% | 73,1 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 8,65 9,36 -7.58% | -0,76 -0,52 -45.68% | 9,82 9,70 1.19% | 15,6 16,3 -4.22% | 20,0 20,1 -0.32% | 21,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 9,04 9,75 -7.23% | -0,62 -0,38 -60.65% | 9,84 9,73 1.12% | 16,2 16,4 -1.5% | 21,7 21,7 0.18% | 23,0 |
|
Net income Million USD | Released Forecast Spread | 9,63 8,59 12.09% | 1,37 1,50 -8.43% | 9,33 7,75 20.39% | 12,8 12,9 -0.31% | 17,2 17,2 -0.04% | 18,1 |
|
EPS USD | Released Forecast Spread | 0,78 0,70 11.43% | 0,11 0,12 -8.33% | 0,74 0,62 19.35% | 1,02 1,01 0.99% | 1,35 1,35 0% | 1,39 |
| Announcement Date | 06/02/20 | 04/02/21 | 04/02/22 | 02/02/23 | 08/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 11,9 11,7 1.8% | 12,3 12,2 0.81% | 12,7 12,6 0.64% | 13,4 13,2 1.78% | 14,9 14,9 -0.42% | 15,5 14,7 5.27% | 16,1 15,7 2.99% | 16,5 16,2 2.18% | 17,5 17,5 -0.27% | 17,6 17,1 2.73% | 17,7 | 17,6 | 20,2 |
|
EBIT Million USD | Released Forecast Spread | 3,11 2,99 3.86% | 3,07 3,08 -0.2% | 4,17 3,38 23.38% | 4,13 3,79 8.95% | 4,25 4,94 -13.92% | 4,01 3,72 7.74% | 4,96 4,22 17.71% | 5,91 5,11 15.47% | 5,16 5,20 -0.77% | 4,75 4,47 6.19% | 4,92 | 5,28 | 6,06 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 3,11 3,00 3.65% | 3,06 3,09 -0.91% | 4,18 3,38 23.51% | 4,24 3,80 11.51% | 4,70 4,95 -4.96% | 4,35 3,92 10.97% | 5,30 4,54 16.8% | 6,41 5,43 17.93% | 5,68 5,70 -0.32% | 5,24 4,98 5.37% | 5,42 | 5,78 | 6,56 |
|
Net income Million USD | Released Forecast Spread | 3,89 2,31 68.3% | 2,49 2,32 7.37% | 3,24 2,59 25.19% | 3,43 2,89 18.67% | 3,67 3,71 -1.06% | 3,41 2,99 13.93% | 4,18 3,50 19.36% | 5,07 4,27 18.63% | 4,54 4,50 0.88% | 4,14 3,85 7.54% | 4,26 | 4,54 | 5,15 |
|
EPS USD | Released Forecast Spread | 0,31 0,18 72.22% | 0,20 0,18 11.11% | 0,26 0,20 30% | 0,27 0,23 17.39% | 0,29 0,29 0% | 0,27 0,24 12.5% | 0,33 0,28 20% | 0,40 0,34 19.4% | 0,36 0,35 2.86% | 0,32 0,30 6.67% | 0,33 | 0,35 | 0,40 |
| Announcement Date | 04/02/22 | 29/04/22 | 29/07/22 | 03/11/22 | 02/02/23 | 04/05/23 | 03/08/23 | 03/11/23 | 08/02/24 | 02/05/24 | - | - | - |
| 06/05/2024 | SHOCKWAVE MEDICAL, INC.: Q1 2024 Earnings Release |
| 07/05/2024 01:39 am | SI-BONE, INC.: Q1 2024 Earnings Release |
| 08/05/2024 01:35 am | MASIMO CORPORATION: Q1 2024 Earnings Release |
| 08/05/2024 01:35 am | TREACE MEDICAL CONCEPTS, INC.: Q1 2024 Earnings Release |
| 08/05/2024 01:35 am | PENUMBRA, INC.: Q1 2024 Earnings Release |
| 08/05/2024 | CHEMOMETEC A/S: Q3 2024 Earnings Release |
| 09/05/2024 | WON TECH CO.,LTD.: Q1 2024 Earnings Release (Projected) |
| 14/05/2024 | I-SENS, INC.: Q1 2024 Earnings Release (Projected) |
| 15/05/2024 | ASAHI INTECC CO., LTD.: Q3 2024 Earnings Release |
| 15/05/2024 | IMPLANTICA AG: Q1 2024 Earnings Release |
Past sector events for IRADIMED CORPORATION
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- IRMD Stock
- Calendar IRADIMED CORPORATION
